Skip to main content

What the FDA labels say about taking them together

Docetaxel and thalidomide

Thalidomide's FDA label of March 24, 2023 names docetaxel in its drug interactions section; the docetaxel labels PlainMeds reads (4) do not name thalidomide.

Check it at the source: the docetaxel FDA label on DailyMed (effective July 15, 2025, Avyxa Pharma, LLC); the thalidomide FDA label on DailyMed (effective March 24, 2023, Celgene Corporation).

What does the docetaxel label say about thalidomide?

Docetaxel's label (effective July 15, 2025) and its 3 other brand-application labels do not name thalidomide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (DOCIVYX), Avyxa Pharma, LLC, effective July 15, 2025 (SPL set 4763744e-360e-4d37-be05-cce4114548cd), via openFDA; the full label on DailyMed

What does the thalidomide label say about docetaxel?

Thalidomide label, drug interactions

Drugs which Cause Peripheral Neuropathy The use of drugs which cause peripheral neuropathy (e.g., bortezomib, amiodarone, cisplatin, docetaxel, paclitaxel, vincristine, disulfiram, phenytoin, metronidazole, alcohol) can cause an additive effect and should be used with caution.

Source: FDA drug label (Thalomid), NDA020785 (Bristol-Myers), as published by Celgene Corporation, effective March 24, 2023 (SPL set 2eda833b-1357-4ed4-a093-194524fcb061), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Docetaxel generic labelers
0Thalidomide generic labelers
DocetaxelThalidomide
Labeled forBreast cancer, Lung cancer, Prostate cancerLeukemia, lymphoma and myeloma
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?